Figure 3.

Overall survival, Kaplan-Meier survival estimate. A, c.35 G > A KRAS mutant patients versus other KRAS mutant plus KRAS wild-type patients; B, c.35 G > A KRAS mutant patients versus KRAS/BRAF wild-type patients; C, c.35 G > A KRAS mutant patients versus other codon 12 KRAS mutant patients; D, c.35 G > A KRAS mutant patients versus c.35 G > T KRAS mutant patients.

Bruera et al. BMC Medicine 2013 11:59   doi:10.1186/1741-7015-11-59
Download authors' original image